Cargando…
Are Noradrenergic Transmission Reducing Drugs Antidepressants?
Major depressive disorder (MDD) remains a significant public health problem worldwide, and revised treatment strategies are therefore urgently needed, including the creation of novel antidepressant compounds or using existing molecular entities in new ways. Etiologic theories of MDD from decades ago...
Autor principal: | Fitzgerald, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514666/ https://www.ncbi.nlm.nih.gov/pubmed/34658805 http://dx.doi.org/10.3389/fnbeh.2021.673634 |
Ejemplares similares
-
Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities
por: Fitzgerald, Paul J., et al.
Publicado: (2021) -
Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
por: Kindt, Merel, et al.
Publicado: (2014) -
Considerations of Pool Dimensions in the Forced Swim Test in Predicting the Potential Antidepressant Activity of Drugs
por: Rosas-Sánchez, Gilberto Uriel, et al.
Publicado: (2022) -
Antimicrobial activity of antidepressants on normal gut microbiota: Results of the in vitro study
por: Rukavishnikov, Grigory, et al.
Publicado: (2023) -
Mechanisms Underlying the Antidepressant Effect of Acupuncture via the CaMK Signaling Pathway
por: Bai, Lu, et al.
Publicado: (2020)